Hemab Therapeutics ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.

Biotechnology

Life Sciences

Pharmaceutical

Hemab

Benny Sorensen

Erik Bjornson

Joe Vogel

Shea Golden

Kathryn Zwetchkenbaum

Emil Poulsen

Jigar Amin

Rane Harrison

Shivangi Mathy

Ashley Gosnell

Mattias Häger

Cécile Bonvoisin

Louise Kempf-Amkær

Helle Elisabeth Gluver Nørgaard

Carnbring Bonde

Klaus Krainer Jønsson

Prafull Gandhi

Henrik Østergaard

Catherine Rea

Mads Behrndt

Manufacturing and Development Team

Clinical Research Team

Leadership Team

Finance and Accounting Team

Medical Affairs Team

Teams at Hemab

Manufacturing and Development Team

Clinical Research Team

Leadership Team

Finance and Accounting Team

Medical Affairs Team